New genes have been identified that can change the way cancer treatments were being done until now. The study has been published in Molecular Cancer Journal.
"Multidrug resistance renders treatment failure in a large proportion of head and neck squamous cell carcinoma (HNSCC) patients that require multimodal therapy involving chemotherapy in conjunction with surgery and/or radiotherapy," the researchers from Queen Mary University have said.
